Cardiovascular disease is the leading cause of death in Manitoba. MindSet and Novartis Pharmaceuticals Canada Inc. are working together to learn more about uncontrolled cholesterol, the impact on Manitobans and their families, as well as the healthcare system as a whole. What does the data tell us? How can we use this information to reduce heart attacks and strokes in Manitoba?
Stay tuned for more updates!
For more information, please contact:
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.